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Abstract  56 
Background 57 
Stillbirth is a global health problem. The World Health Organization (WHO) application of the 58 
International Classification of Diseases for perinatal mortality (ICD-PM) aims to improve data on 59 
stillbirth to enable prevention.  60 
Objectives 61 
To identify globally reported causes of stillbirth, classification systems, and alignment with the ICD-62 
PM. 63 
Search strategy 64 
We searched CINAHL, EMBASE, Medline, Global Health and Pubmed from 2009-2016. 65 
Selection criteria 66 
Reports of stillbirth causes in unselective cohorts. 67 
Data collection and analysis 68 
Pooled estimates of causes were derived for country representative reports. Systems and causes were 69 
assessed for alignment with the ICD-PM. Data are presented by income setting (low, middle and high 70 
income; LIC, MIC, HIC). 71 
Main results 72 
85 reports from 50 countries (489,089 stillbirths) were included. The most frequent categories were 73 
Unexplained, Antepartum haemorrhage and Other (all settings), Infection and Hypoxic peripartum 74 
(LIC), and Placental (MIC, HIC). Overall report quality was low. Only one classification system 75 
fully aligned with ICD-PM. All stillbirth causes mapped to ICD-PM. In a subset from HIC mapping 76 
obscured major causes. 77 
Conclusion  78 
There is a paucity of quality information on causes of stillbirth globally. Improving investigation of 79 
stillbirths and standardisation of audit and classification is urgently needed and should be achievable 80 
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in all well-resourced settings. Implementation of the WHO Perinatal Mortality Audit and Review 81 
guide particularly across high burden settings is needed.   82 
Funding 83 
HR, SH, SHL and AW were supported by a NHMRC-CRE grant (APP xxxxxx). VF was funded by 84 
a NHMRC-CDF (APP xxxxx). 85 
Keywords 86 
Stillbirth, classification, systems, cause of death, ICD 87 
Tweetable Abstract  88 
Urgent need to improve data on causes of stillbirths across all settings to meet global targets. 89 
 90 
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Introduction  91 
The global stillbirth rate (≥28 completed weeks’ gestation) is estimated to be 18.4 per 1000 births1 or 92 
around 2.6 million stillbirths each year1. The World Health Organization’s (WHO’s) Every Newborn 93 
Action Plan aims to reduce the stillbirth rate to 12 or fewer per 1000 births by 2030 in every country, 94 
and for countries already meeting this target to reduce equity gaps2. However, with an estimated 95 
annual reduction rate of 2.0% between 2000 and 20151, half that for neonatal deaths, progress has 96 
been slow. Identifying interventions to achieve such a target would be facilitated by cross-country 97 
and inter-country comparisons of the causes of stillbirth. Moreover, while national neonatal causes 98 
of death are regularly published through the United Nations1,3, there is currently no systematic global 99 
reporting of causes of stillbirth. The WHO recommends use of the International Statistical 100 
Classification of Diseases and Health Related Problems (ICD) for classification of perinatal deaths 101 
for international reporting4. However, limitations in ICD for classifying stillbirths5 has resulted in 102 
numerous disparate systems currently in use6, thus limiting global comparisons. In 2016, WHO 103 
released ICD Perinatal Mortality (ICD-PM) as part of the WHO Perinatal Mortality Audit and Review 104 
guide7. The ICD-PM is an application of ICD and holds promise as an important step in improving 105 
global and local reporting of causes of stillbirths and neonatal deaths8. The ICD-PM aims to collect, 106 
at a minimum, timing of death and clinically defined causes and associated conditions. 107 
Objectives  108 
Following on the introduction of the ICD-PM, we aimed to identify globally reported causes of 109 
stillbirth in order to support progress toward the WHO Every Newborn Action Plan stillbirth rate 110 
target. The specific objectives were to: 111 
1. Describe the current status of global reporting of stillbirth causes, including reported causes 112 
and classification systems used; 113 
2. Pool results from country representative reports to identify commonly reported causes of 114 
stillbirth, stratified by income setting (high-, middle-, and low-income); and 115 
   Page | 6 
3. Assess alignment of systems used and reported causes of stillbirths with the ICD-PM for 116 
country representative reports.  117 
Methods 118 
This systematic review was conducted and reported according to the PRISMA checklist9. The 119 
protocol has not been published. Two authors independently undertook screening of reports, 120 
selection, data extraction and quality assessment. 121 
Eligibility criteria 122 
All published and unpublished cohort and cross-sectional reports from 1 January 2009 to 31 123 
December 2016 which presented causes of stillbirth were eligible. Reports were excluded if they: 124 
included non-consecutive or selected subgroups, e.g. preterm; aimed only to identify risk factors or 125 
did not provide data on causes in an extractable format (for complete study selection see Figure S1).  126 
Information sources 127 
We searched PubMed, Global Health, Cinahl, Medline and Embase without language restrictions. 128 
We identified national reports through web-based systematic searches (Appendix S1) and cross-129 
referenced included reports. 130 
Study selection 131 
Titles and abstracts of identified reports were screened for eligibility; full text papers were retrieved 132 
if potentially eligible or unsure. All reports presenting causes of stillbirth were included to address 133 
Objective 1. To address Objectives 2 and 3, the most recent national report for each country was 134 
selected. If a national report was unavailable, a report was selected on criteria (in descending order): 135 
1) population-based report with the largest number of stillbirths, 2) multi-centre health facility report 136 
covering the largest population.  137 
Data extraction  138 
A purpose built data extraction form was used. For details on data items and definitions used, see 139 
Additional Information S2.  140 
Grouping reported stillbirth causes 141 
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The development of categories and mapping of reported causes of stillbirth to categories 142 
were undertaken by a panel including Maternal Fetal Medicine Specialists (GG, BS, DE), pathologist 143 
(RL) and epidemiologist (VF), with guidance from The Amsterdam Classification Workshop10 144 
members. Categories were created by “clustering” reported causes into 15 clinically meaningful 145 
groups for stillbirth prevention (“global categories”) (Table S1). With the addition of Placental 146 
conditions, these categories generally coincided with previously suggested major causal groupings 147 
by Lawn et al11. We did not attempt to differentiate causes from associated conditions (Table S1). 148 
Quality assessment  149 
Quality assessment of country representative reports included in the pooled analysis of reported 150 
causes was performed using an adapted version of the Joanna Briggs Institute Critical Appraisal 151 
Checklist for Studies Reporting Prevalence Data12 (Appendix S3). An overall quality rating was 152 
derived for each report (low, medium, or high quality). For subgroup analyses of “good” quality 153 
reports, we combined data from reports assessed as high and medium quality. 154 
Data presentation and analysis 155 
Data were presented by income setting using World Bank groupings13 of low and lower-middle (LIC; 156 
Gross National Income (GNI) ≤$3,955), upper-middle (MIC; GNI $3,956- $12,235) and high (HIC; 157 
GNI ≥$12,236). Categories of stillbirth causes were presented as proportions of the total number of 158 
stillbirths classified. Results from country representative reports were statistically pooled to identify 159 
commonly reported causes stratified by country groupings. Analyses were done in R using the meta 160 
package14 with 95% prediction intervals (PI)15-17 (Appendix S4). Subgroup analyses by report quality 161 
and type of system (ICD versus clinical classification systems) were planned a priori. See Appendix 162 
S2 for definition of clinical classification systems6 and criteria for alignment of classification systems 163 
with ICD-PM.  164 
Each reported cause was mapped to the relevant ICD-PM major category. The ICD-PM includes five 165 
major maternal condition categories (M1-5) and 13 fetal categories, six with antepartum timing (A1-166 
6) and seven with intrapartum timing (I1-7)4. For the Unknown (U) timing category we included the 167 
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categories: U1: Congenital malformations, deformations and chromosomal abnormalities; U2: 168 
Infection; U3: Other specified disorder; U4: Disorders related to fetal growth; U5: Death of 169 
unspecified cause. We added one category, Other, to all timings to accommodate the causes without 170 
ICD-PM coding.  171 
The proportions of stillbirths that could be mapped to a fetal cause and/or a maternal condition in 172 
ICD-PM were calculated. Mapping of data from good quality HIC reports to ICD-PM was compared 173 
descriptively with the 15 global categories.  174 
Results 175 
Of 7415 abstracts screened for eligibility, 909 full-text papers were reviewed for inclusion and 824 176 
records were excluded: did not discuss stillbirth (396), no extractable data (217), sub-populations 177 
only (145), risk factors only (12) (for complete study selection see Figure S1). Eighty-five reports 178 
(LIC 28, MIC 20, HIC 37) with a total of 489,089 stillbirths were included in the review (LIC 13,197, 179 
MIC 431,216, HIC 44,676). Thirty-three country representative reports classifying 454,533 stillbirths 180 
were included in the pooled analysis of causes and mapping to ICD-PM.  181 
Global stillbirth reporting 182 
Description of included reports  183 
The 85 included reports originated from 50 countries. Reports were published in English (66) and 184 
non-English (19; Table S2). Eleven reports excluded terminations of pregnancy. Half of the reports 185 
(including 2.4% of all stillbirths) were from hospital settings (LIC: 19 reports/7419 stillbirths; MIC: 186 
8 reports/1134 stillbirths; HIC: 16 reports/3240 stillbirths) (Table 1, for full details see Table S2).  187 
Definitions of stillbirth  188 
Stillbirth was defined in 71 reports (84%) using 34 discrete definitions (Figure S2). The majority of 189 
HIC reports (78%) used a lower gestational age limit of 20-24 weeks while the majority of LIC reports 190 
(68%) used 28 weeks (Table 1). 191 
Data available to classifiers 192 
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Systematic prospective perinatal mortality audits were used in 21 reports (LIC 2, MIC 4, HIC 15), of 193 
which 12 were hospital audits; seven used comprehensive investigation protocols (all from HIC) 194 
(Table S2). In 40 reports, retrospective audit data were used; 18 of these (LIC 2, MIC 6, HIC 10) 195 
sourced causes from Civil Registration and Vital Statistics (CRVS). Sixteen reports (LIC 13, MIC 3) 196 
were prospective studies; eight of these, all from LIC, used verbal autopsy. Reported autopsy rates in 197 
20 reports [MIC 3 (14%), HIC 17 (47%)] ranged from 2.7% to 100%. In over half of the reports 198 
(55%) it was unclear whether autopsy had been performed. Placental pathology examination rates 199 
were included in 15 reports (18%) (none in LIC) with rates ranging from 22% to 100%.  For full 200 
details on data available see Table S2.  201 
Classification systems  202 
Twenty-one clinical classification systems18-38 were used in 41 of the 85 reports (LIC 15 reports/30% 203 
of stillbirths, MIC 6 reports/5% of stillbirths, HIC 20 reports/27% of stillbirths). The ICD was used 204 
more frequently in HIC (14 reports/72% of stillbirths) and MIC (7 reports/94% of stillbirths) than 205 
LIC (3 reports/2% of stillbirths) (Table 1). The remaining 20 reports listed causes of death without 206 
reference to any classification system. Areas of origin for the 21 clinical systems is shown in Table 207 
S3. Three-quarters of the systems allow a single primary cause of death, and half the systems allow 208 
associated factors to be recorded (Table S4). Five systems provide comprehensive definitions of 209 
causes20,27,30-32 and 13 systems provide rules for assigning cause of death (See Table S4 for full details 210 
on clinical classification systems). 211 
Globally reported categories of stillbirth  212 
The 85 included reports presented causes of stillbirth using 860 unique terms. These were grouped 213 
into 15 global categories and 46 minor categories, of which eight major categories were common to 214 
over half (53%) of the reports (Table S5). 215 
Congenital anomalies was the most frequently reported category, included in 93% of all reports. The 216 
proportion of stillbirths assigned to this category ranged from 1.4% in Nigeria39 to 64.4% in China40 217 
(Figure 1, Table S5). The second category was Unexplained, included in 82% of all reports, ranging 218 
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from 0.3% in Turkey25 to 82.0% in Japan41. Maternal conditions were included in 64% of all reports, 219 
with frequency ranging from 0.6% in Ireland42 to 36.5% in Italy28 (Figure 1, Table S5).  220 
The proportions of categories also differed across type of classification system. The most commonly 221 
reported categories for reports using the ICD included Other unspecified condition (68% of reports) 222 
and Hypoxic peripartum death (64%), whereas for clinical systems these included Antepartum 223 
haemorrhage (72%) and Infection (67%). 224 
Country representative reports 225 
Description of included reports  226 
Thirty-three reports classifying 454,533 stillbirths were included in the pooled analysis: seven LIC 227 
(5,629 stillbirths), 11 MIC (429,666 stillbirths), and 15 HIC (19,238 stillbirths). Twenty-one reports 228 
included ≥95% of total stillbirths in the country during the reporting period, one report included 72%, 229 
three included 6-49% and eight included ≤5% (Figure S3). In two reports (6%), terminations of 230 
pregnancy were excluded, and in 21 (64%), no reference was made to terminations. The ICD was 231 
used mainly in HIC and MIC reports (60% and 64%, respectively, versus 14% of LIC reports; Table 232 
1, Table S2). 233 
Quality assessment identified 13 good quality reports (29% of all LIC reports, 36% of all MIC reports, 234 
47% of all HIC reports); only one of these was high-quality43. The remaining reports were assessed 235 
as low-quality (Table S6, Figure S4). 236 
Pooled estimates of commonly reported causes of stillbirths 237 
The top five categories by frequency for each country grouping are shown in Figure 2. Unexplained 238 
was the top category across all settings, with pooled estimated ranging from 31.2% to 43.7% (Tables 239 
S7, S8). Two additional categories were amongst the top five across all settings: Other unspecified 240 
conditions (9.3% to 11.6%) and Antepartum haemorrhage (8.4% to 9.3%; Tables S7, S9, S10). In 241 
LIC, Infection (15.8%) and Hypoxic peripartum death (11.6%; Tables S7, S11, S12) were also 242 
amongst the top five. In both HIC and MIC settings Placental conditions (14.4% and 13.7%, 243 
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respectively) ranked in the top five, with Congenital anomalies as the remaining category in HIC 244 
(14.0%) and Specific fetal/pregnancy pathology in MIC (11.0%) (Tables S7, S13, S14, S15).  245 
Details of pooled analyses of Umbilical cord complications, Maternal conditions, Spontaneous 246 
preterm, Hypertension, Fetal growth restriction and Terminations are presented in Tables S16-S21.   247 
Sub-group analysis 248 
Due to insufficient data subgroup analysis by report quality was only possible for HIC. The proportion 249 
of Unexplained (15.4% vs 31.6%) and Other unspecified conditions (1.6% vs 9.3%) was lower in 250 
good quality reports versus all reports (Tables S8, S9). Subgroup analyses by system type showed 251 
higher proportions of Antepartum haemorrhage using clinical systems (14.1%) than using ICD 252 
(4.4%) in MIC (Table S10). Use of clinical systems resulted in lower proportions of Other unspecified 253 
conditions (1.6%) and Unexplained (17.7%) than use of ICD (13.2% and 43.4%, respectively) in HIC 254 
(Tables S9, S8).  255 
Alignment with the ICD-PM 256 
Alignment of clinical classification systems with the ICD-PM 257 
Of 21 classification systems used, only Codac19 was fully aligned with the ICD-PM. Four systems 258 
met two of the three criteria used to assess alignment, and 14 systems scored 0.5-1.5 out of a 259 
maximum of 3 (Table S3, Figure S5). 260 
Mapping of reported causes to ICD-PM 261 
Nearly all the 454,533 stillbirths reported in the 33 country representative reports were mapped to an 262 
ICD-PM fetal or maternal category, or both. Causes for 831 stillbirths (0.2%) mapped to ICD-PM 263 
neonatal rather than fetal codes (for example “neonatal aspiration syndrome”). 264,480 stillbirths 264 
(58%) were mapped to a fetal but not a maternal ICD-PM cause, and 140,319 (31%) to a maternal 265 
but not a fetal ICD-PM cause; 49,734 stillbirths (11%) were mapped to both (Tables S22, S23). 266 
Of the 204,545 stillbirths in the global category Unexplained, 113,558 (56%) were mapped to the 267 
ICD-PM category Unknown timing unspecified (no maternal condition), 90,335 (44%) to Antepartum 268 
hypoxia (no maternal condition), 602 (0.3%) to Antepartum unspecified (no maternal condition), and 269 
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50 (0.02%) to maternal condition Other complications of labour and delivery (no fetal cause) (Tables 270 
S22, S23).  271 
The global causes from best available data (good quality reports using clinical classification systems 272 
in HIC, five reports; 6,194 stillbirths) were mapped to ICD-PM. The global categories reflecting 273 
underlying placental causes of Antepartum haemorrhage and Placental condition (insufficiency) 274 
accounted for 20%, and Intrauterine growth restriction 7% of stillbirths (Figure 3). When mapped to 275 
the ICD-PM, these global categories are included within the major maternal category Complications 276 
of placenta, cord and membranes and the fetal category Disorders related to fetal growth, accounting 277 
for 30% and 17% of stillbirths, respectively (Figure 3).  278 
Discussion  279 
Main findings 280 
From 85 reports presenting causes of nearly half a million stillbirths from 50 countries and all income 281 
settings, we identified 15 major causal categories from nearly 900 causal terms; eight categories were 282 
common to the majority of reports. Despite this overarching commonality, we found wide variation 283 
in frequency of stillbirth categories and in the systems used to classify them with generally poor 284 
quality data. Underlining one of the key challenges of achieving the Every Newborn Action Plan 285 
stillbirth target, are the high proportions of stillbirths without information to guide prevention 286 
(Unexplained and Other unspecified conditions) in all income settings. 287 
Strengths and limitations 288 
We sought to include the most detailed causes of stillbirth available to allow identification of common 289 
groupings, and ultimately to enable consistent reporting across settings. In line with WHO 290 
recommendations4,44 and to maximize the utility of the data for prevention strategies, we excluded 291 
reports which assigned more than one cause of stillbirths and excluded all those reported as associated 292 
only. This may have resulted in a loss of information and limited our ability to assess the full value 293 
of the ICD-PM, which aim to record both a fetal and a maternal condition for every stillbirth. The 294 
need to assign multiple causes for some stillbirths has been highlighted. Further, the distinction 295 
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between causes and associated conditions is often poorly defined26 and in this review many reported 296 
“causes” are not recognised as causal conditions. Further, although we imposed no language 297 
restriction, we may have missed some reports due to English-language search terms. 298 
Interpretation 299 
Data quality 300 
Data quality was generally poor with only a small number of reports based on high quality perinatal 301 
mortality audit. Further, many reports did not provide sufficient detail to adequately assess quality. 302 
Similar to others1,5,45, we found global comparisons problematic due to differing definitions and 303 
systems. The inability to identify termination of pregnancies in reporting of stillbirth causes is 304 
problematic; many are terminated as a consequence of congenital anomalies46, some of which may 305 
not have resulted in stillbirth.  306 
Global causes of stillbirth 307 
Results of the pooled analysis enabled comparisons of stillbirth causes across settings, providing 308 
additional evidence for key areas for prevention. The relatively high proportion of stillbirths attributed 309 
to intrapartum hypoxia (Hypoxic peripartum) in LIC versus HIC and MIC is in line with recent 310 
evidence from low- and middle-income countries (LMIC)47,48 and confirms the urgency of improving 311 
care during labour and birth, when half of all global stillbirths occur1,3,47,49. Further, similar to other 312 
reports47,48 we identified infection as a top cause of stillbirths in LIC, confirming the importance of 313 
infection prevention and management3,49,50. Our findings clearly highlight the importance of placental 314 
conditions as a major contributor to stillbirths in all settings, consistent with other recent studies47,51. 315 
However, many placental conditions were ill-defined and the causal link unclear (for instance delayed 316 
villous maturation)52,53. Many conditions that lead to stillbirth are also linked to neonatal deaths and 317 
therefore both must be accommodated within a single system to ensure optimal pregnancy care and 318 
outcomes54.  319 
ICD-PM and progress towards global reporting  320 
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We confirmed findings of other studies, showing numerous disparate systems for classification of 321 
stillbirths in use globally5,45,55, further highlighting the need for a globally effective classification 322 
system. A recent consensus described user-identified characteristics for such a system56, however no 323 
existing systems meet these characteristics57. Further, robust evaluation of system performance is 324 
limited6. The ICD-PM is the first system intended for global use in classification of perinatal 325 
deaths4,58-60, aiming to facilitate comparisons by improving perinatal mortality data, particularly in 326 
high burden settings. While evaluation of the performance of ICD-PM is currently limited, 327 
retrospective application to datasets in the UK and South Africa highlighted its values and provided 328 
insights to future improvements59. In our dataset, all causes of stillbirths reported globally could be 329 
accommodated within the ICD-PM. However, our mapping of causes from good quality reports in 330 
HIC using clinical classification systems highlights that classification system needs differ across 331 
settings. Meeting the needs of diverse settings is essential for global comparisons to identify important 332 
variation and inform programmatic change to reduce deaths. 333 
The WHO Perinatal Mortality Audit and Review guide7 provides a tool to initialize audits in low-334 
income settings using the ICD-PM for classifying perinatal deaths. The ICD-PM maps ICD-10 codes 335 
to an underlying fetal cause of antepartum, intrapartum or unknown timing, and a maternal condition; 336 
thus, data collection must include timing as well as fetal and a maternal condition. While this approach 337 
aims to capture information on stillbirths from low resource settings (either cause and/or associated 338 
conditions) the ICD-PM faces challenges due to its ICD-10 provenance, including insufficient 339 
differentiation of causes from associated conditions, and insufficient detail on maternal conditions8. 340 
Conditions noted as Maternal in the ICD-PM include not only fetal underlying causes (Placenta, cord 341 
and membranes), but also maternal causes (Maternal complications of pregnancy) and maternal 342 
associated conditions (Maternal medical and surgical conditions). Further, one-fifth of stillbirths in 343 
the global category Unexplained mapped to ICD-PM Antepartum asphyxia. Classifying associated 344 
conditions is important, particularly in data poor settings where assigning cause may be difficult. 345 
However confusing causes from associated conditions or mechanisms of deaths (antepartum 346 
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asphyxia) while reducing the number of Unexplained, may obscure key areas for prevention. WHO 347 
is currently working towards ICD-11 which provides an opportunity to alleviate some of these 348 
issues[World Health Organization,  #269]. 349 
Differences in proportions of causal categories across countries, were likely due to different 350 
classification approaches. Codac19 was the only non-ICD system fully aligned with the ICD-PM. 351 
Although Codac has previously been shown to be the best-performing system45, the majority of 352 
stillbirths classified using Codac were mapped to unknown timing and cause within the ICD-PM (data 353 
not shown). Codac also resulted in a high proportion of Unexplained stillbirths, potentially influenced 354 
by the categories included. Moreover, this system was only aligned with nine of the 17 user-identified 355 
characteristics for an effective global system. Future enhancements to global classification of 356 
stillbirths need to incorporate user-identified characteristics for an effective global system. Further, 357 
optimisation of information from data-rich settings to incorporate recent advances in stillbirth 358 
aetiology such as the consensus on placental pathology53, and other detailed laboratory investigations 359 
will serve to advance prevention of stillbirths globally. Implementation of any system must also be 360 
accompanied by appropriate training to ensure high-quality data.  361 
Conclusion 362 
To achieve the Every Newborn Action Plan global stillbirth rate target, improving care of women in 363 
labour and birth and preventing and treating infections and the quality of data on causes to drive 364 
change are priorities. Implementation of ICD-PM as part of the WHO Perinatal Mortality Audit and 365 
Review guide7 would be a major step forward. While the ICD-PM captures data from high-burden 366 
settings by allowing for a minimum of timing and clinically defined causes and associated conditions, 367 
a global system must also accommodate needs of data-rich settings to enable global comparisons. 368 
Clearly ascertaining underlying causes separate from associated conditions and enabling capture of 369 
more detailed information in data-rich settings will fully harness the ICD-PM’s potential for global 370 
reporting and prevention of stillbirths. Further research is needed to improve the classification of 371 
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placental causes of stillbirths. Enhancements to global classification of stillbirths and neonatal deaths 372 
must be based on comprehensive testing across diverse settings.  373 
Acknowledgements 374 
We sincerely thank Kirsty Rickett, librarian, for assisting with systematic literature searches and Jane 375 
Fox, Viviana Rodriguez, Amber Rajpari and Erica Woonji Jang for assisting with data extraction. We 376 
also thank Rafaela Augusto Neman Dos Santos, Urelija Rodin and Amanda Quach for assisting with 377 
translations of non-English papers. We thank KS Joseph for advice on data sources in Canada, and 378 
Metin Gülmezoglu for advice on methodology. 379 
Disclosure of Interests 380 
GS receives/has received research support from GE (supply of two diagnostic ultrasound systems), 381 
from Roche (supply of equipment and reagents for biomarker studies, value £596,142) and from GSK 382 
(£199,413 for in vitro studies on human myometrium). GS has been paid to attend advisory boards 383 
by GSK and Roche. GS has acted as a paid consultant to GSK. GS has received support to attend a 384 
scientific meeting from Chiesi. GS is named inventor in a patent submitted by GSK for a novel 385 
application of an existing GSK compound for the prevention of preterm birth (PCT/EP2014/062602). 386 
GS was a member of a GSK Data Safety Monitoring Committee for a trial of RSV vaccination in 387 
pregnancy and infancy, 2016-2017. 388 
 Contribution to Authorship 389 
HR was responsible for the conduct of the study. VF conceptualized the study and developed methods 390 
and procedures with HR, MC and SHL. HR, VF, SHL, AW and ZT undertook searches, selection of 391 
studies, data extraction and quality assessment. GG, DE, RL and VF created the global stillbirth 392 
categories. MC oversaw all statistical aspects of the study and undertook the pooled analysis. VF and 393 
SHL undertook the assessment of ICD-PM alignment with advice from RP, JG, ÖT and EA. HR and 394 
VF were responsible for interpretation of findings and preparation of the first draft of the manuscript. 395 
   Page | 17 
SH, AW, GG, RL, DE, ZT, EA, HB, ED, JJE, FF, JG, KG, SG, AG, AH, YK, FK, JL, EM, JO, RP, 396 
KP, DS, RS, GS and ÖT have been actively involved throughout planning and consultation stages of 397 
the project and provided comments on the manuscript. HR, SHL, MC, SH, AW, GG, RL, DE, ZT, 398 
EA, HB, ED, JJE, FF, JG, KG, SG, AG, AH, YK, FK, JL, EM, JO, RP, KP, DS, RS, GS and ÖT 399 
approved the final version. All authors are part of The International Stillbirth Alliance Collaborative 400 
for Improving Classification of Perinatal Deaths. 401 
Details of Ethics Approvals 402 
Not required 403 
Funding 404 
HR, SH, SHL and AW were supported in part by a National Health and Medical Research Council 405 
(NHMRC) Centre of Research Excellence grant. VF was funded by a NHMRC Career Development 406 
Fellowship.   407 
   Page | 18 
References  408 
1. Lawn JE, Blencowe H, Waiswa P, Amouzou A, Mathers C, Hogan D, et al. Stillbirths: Rates, 409 
risk factors and potential for progress towards 2030. Lancet. 2016;387(10018):587-603. 410 
2. World Health Organisation. Every newborn: An action plan to end preventable deaths. Geneva: 411 
World Health Organisation; 2014. 412 
3. Lawn JE, Blencowe H, Pattinson R, Cousens S, Kumar R, Ibiebele I, et al. Stillbirths: Where? 413 
When? Why? How to make the data count? Lancet. 2011;377(9775):1448-63. 414 
4. World Health Organisation. The WHO application of ICD-10 to deaths during the perinatal 415 
period: ICD-PM. Geneva, Switzerland: WHO, 2016. 416 
5. Frøen JF, Gordijn SJ, Abdel-Aleem H, Bergsjo P, Betran A, Duke CW, et al. Making stillbirths 417 
count, making numbers talk - issues in data collection for stillbirths. BMC Pregnancy Childbirth. 418 
2009;9(58). 419 
6. Leisher SH, Teoh Z, Reinebrant H, Allanson E, Blencowe H, Erwich JJ, et al. Seeking order 420 
amidst chaos: A systematic review of classification systems for causes of stillbirth and neonatal death, 421 
2009–2014. BMC Pregnancy Childbirth. 2016;16(1):295. 422 
7. World Health Organization. Making every baby count; Audit and review of stillbirths and 423 
neonatal deaths. Geneva, Switzerland: 2016. 424 
8. Allanson ER, Tunçalp Ӧ, Gardosi J, Pattinson RC, Vogel JP, Erwich J, et al. Giving a voice to 425 
millions: developing the WHO application of ICD-10 to deaths during the perinatal period: ICD-PM. 426 
BJOG. 2016;123(12):1896-99. 427 
9. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic 428 
Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097. 429 
10. Flenady V, Erwich J, Leisher SH, Reinebrant H, editors. Classification Workshop: WHO global 430 
classification systems for stillbirth and neonatal death. ISA/ISPID International Conference; 2014; 431 
Amsterdam, Netherlands. 432 
11. Lawn JE, Yakoob M, Haws RA, Soomro T, Darmstadt GL, Bhutta ZA. 3.2 million stillbirths: 433 
epidemiology and overview of the evidence review. BMC Pregnancy Childbirth. 2009;9(Suppl 1):S2. 434 
12. Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI 435 
systematic reviews, checklist for prevalence studies. Joanna Briggs Institute, 2016. 436 
13. World Bank Group. World bank country and lending groups, country classification: World Bank 437 
Group; 2017 [cited 2017 18th May]. Available from: 438 
https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-439 
lending-groups. 440 
14. Schwarzer G. meta: An R package for meta-analysis. R News. 2007;7(3). 441 
15. Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 442 
2011;342. 443 
16. IntHout J, Ioannidis JPA, Rovers MM, Goeman JJ. Plea for routinely presenting prediction 444 
intervals in meta-analysis. BMJ Open. 2016;6(7). 445 
17. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. 446 
J R Stat Soc Ser A Stat Soc. 2009;172(1):137-59. 447 
18. Flenady V, King J, Charles A, Gardener G, Ellwood D, Day K, et al. PSANZ Clinical Practice 448 
Guideline for Perinatal Mortality. 2009. 449 
19. Frøen JF, Pinar H, Flenady V, Bahrin S, Charles A, Chauke L, et al. Causes of death and 450 
associated conditions (Codac): A utilitarian approach to the classification of perinatal deaths. BMC 451 
Pregnancy Childbirth. 2009;9:22. 452 
20. Manandhar SR, Ojha A, Manandhar DS, Shrestha B, Shrestha D, Saville N, et al. Causes of 453 
stillbirths and neonatal deaths in Dhanusha district, Nepal: A verbal autopsy study. Kathmandu Univ 454 
Med J. 2010;8(29):62-72. 455 
21. The MRC Unit for Maternal and Infant Health Care Strategies PU, and the National Department 456 
of Health,. Saving Babies 2002: Third Perinatal Care Survey of South Africa 2002. 457 
   Page | 19 
22. Manning E, Corcoran P, Meaney S, Greene RA, Group obotPM. Perinatal Mortality in Ireland 458 
Annual Report 2011. Cork: National Perinatal Epidemiology Centre, 2013. 459 
23. Wigglesworth JS. Monitoring perinatal mortality. A pathophysiological approach. Lancet. 460 
1980;2(8196):684-6. 461 
24. Santosh A, Zunjarwad G, Hamdi I, Al-Nabhani JA, Sherkawy BE, Al-Busaidi IH. Perinatal 462 
mortality rate as a quality indicator of healthcare in Al-dakhiliyah region, Oman. Sultan Qaboos Univ 463 
Med J. 2013;13(4):545-50. 464 
25. Duran SS, Kavuncuoğlu S, Sarı F, Aldemir EY, Kavçık N, Demir F. Assesment of perinatal 465 
mortality in two different periods: Results of a single center. Turk Pediatri Arsivi. 2016;51(3):128-466 
34. 467 
26. Dudley DJ, Goldenberg R, Conway D, Silver RM, Saade GR, Varner MW, et al. A new system 468 
for determining the causes of stillbirth. Obstet Gynecol. 2010;116(2 Pt 1):254-60. 469 
27. Varli IH, Petersson K, Bottinga R, Bremme K, Hofsjo A, Holm M, et al. The Stockholm 470 
classification of stillbirth. Acta Obstet Gynecol Scand. 2008;87(11):1202-12. 471 
28. Serena C, Marchetti G, Rambaldi MP, Ottanelli S, Di Tommaso M, Avagliano L, et al. Stillbirth 472 
and fetal growth restriction. J Matern Fetal Neonatal Med. 2013;26(1):16-20. 473 
29. Mo-Suwan L, Isaranurug S, Chanvitan P, Techasena W, Sutra S, Supakunpinyo C, et al. 474 
Perinatal death pattern in the four districts of Thailand: Findings from the propective cohort study of 475 
Thai children (PCTC). J Med Assoc Thai. 2009;92(5):660-6. 476 
30. Nausheen S, Soofi SB, Sadiq K, Habib A, Turab A, Memon Z, et al. Validation of verbal autopsy 477 
tool for ascertaining the causes of stillbirth. PLoS One. 2013;8(10):1-10. 478 
31. Baqui AH, Choi Y, Williams EK, Arifeen SE, Mannan I, Darmstadt GL, et al. Levels, timing, 479 
and etiology of stillbirths in Sylhet district of Bangladesh. BMC Pregnancy Childbirth. 2011;11:25. 480 
32. Pattinson RC, De Jong G, Theron GB. Primary causes of total perinatally related wastage at 481 
Tygerberg Hospital. S Afr Med J. 1989;75(2):50-3. 482 
33. Wou K, Ouellet MP, Chen MF, Brown RN. Comparison of the aetiology of stillbirth over five 483 
decades in a single centre: a retrospective study. BMJ Open. 2014;4(6):e004635. 484 
34. Korteweg FJ, Gordijn SJ, Timmer A, Erwich JJ, Bergman KA, Bouman K, et al. The Tulip 485 
classification of perinatal mortality: introduction and multidisciplinary inter-rater agreement. BJOG. 486 
2006;113(4):393-401. 487 
35. Abha S, Alpana T. Re. Co. De.: A better classification for determination of stillbirths. J Obstet 488 
Gynaecol India. 2011;61(6):656-58. 489 
36. Aggarwal AK, Jain V, Kumar R. Validity of verbal autopsy for ascertaining the causes of 490 
stillbirth. Bull World Health Org. 2011;89(1):31-40. 491 
37. Bapat U, Alcock G, Shah More N, Das S, Joshi W, Osrin D. Stillbirths and newborn deaths in 492 
slum settlements in Mumbai, India: a prospective verbal autopsy study. BMC Pregnancy Childbirth. 493 
2012;12(39). 494 
38. Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. Classification of stillbirth by relevant 495 
condition at death (ReCoDe): Population based cohort study. BMJ. 2005;331(7525):1113-17. 496 
39. Ugwa EA, Ashimi A. An assessment of stillbirths in a tertiary hospital in northern Nigeria. J 497 
Matern Fetal Neonatal Med. 2015;28(13):1585-8. 498 
40. Wan H, Li S, Sun L. Clinical analysis of 121 cases of perinatal death. Modern Preventive 499 
Medicine. 2010;37(1). 500 
41. Statistics Bureau Japan. Chapter 2 population and households. In: Statistics Burearu SJ, editor. 501 
Shinjuku-ku, Tokyo: Statistics Bureau; 2015. 502 
42. Corcoran P, Manning E, O’Farrell I, McKernan J, Meaney S, Drummond L, et al. Perinatal 503 
Mortality in Ireland Annual Report 2014. Cork: National Perinatal Epidemiology Centre, 2016. 504 
43. Ego A, Zeitlin J, Batailler P, Cornec S, Fondeur A, Baran-Marszak M, et al. Stillbirth 505 
classification in population-based data and role of fetal growth restriction: the example of RECODE. 506 
BMC Pregnancy Childbirth. 2013;13(1):182. 507 
44. World Health Organisation. International Statistical Classification of Diseases and Related 508 
Health Problems 10th Revision. WHO, 2016. 509 
   Page | 20 
45. Flenady V, Frøen JF, Pinar H, Torabi R, Saastad E, Guyon G, et al. An evaluation of 510 
classification systems for stillbirth. BMC Pregnancy Childbirth. 2009;9:24. 511 
46. Royal College of Obstetricians and Gynaecologists. Termination of pregnancy for fetal 512 
abnormality in England, Scotland and Wales. London, UK: RCOG, 2010. 513 
47. Aminu M, Unkels R, Mdegela M, Utz B, Adaji S, van den Broek N. Causes of and factors 514 
associated with stillbirth in low- and middle-income countries: A systematic literature review. BJOG. 515 
2014;121(Suppl 4):141-53. 516 
48. McClure EM, Garces A, Saleem S, Moore JL, Bose CL, Esamai F, et al. Global network for 517 
women's and children's health research: Probable causes of stillbirth in low- and middle-income 518 
countries using a prospectively defined classification system. BJOG. 2017. 519 
49. Goldenberg RL, Harrison MS, McClure EM. Stillbirths: The Hidden Birth Asphyxia - US and 520 
Global Perspectives. Clin Perinatol. 2016;43(3):439-53. 521 
50. Goldenberg RL, McClure EM, Saleem S, Reddy UM. Infection-related stillbirths. Lancet. 522 
2010;375(9724):1482-90. 523 
51. The Stillbirth Collaborative Research Network Writing Group. Causes of death among 524 
stillbirths. JAMA. 2011;306(22):2459-68. 525 
52. Khong TY, Ting M, Gordijn SJ. Placental pathology and clinical trials: Histopathology data 526 
from prior and study pregnancies may improve analysis. Placenta. 2017;52:58-61. 527 
53. Khong TY, Mooney EE, Ariel I, Balmus NCM, Boyd TK, Brundler M, et al. Sampling and 528 
definitions of placental lesions - Amsterdam placental workshop group concesus statement. 529 
Amsterdam: Arch Pathol Lab Med; 2016. 530 
54. Goldenberg RL, McClure EM, Bhutta ZA, Belizan JM, Reddy UM, Rubens CE, et al. Stillbirths: 531 
The vision for 2020. Lancet. 2011;377(9779):1798-805. 532 
55. Aminu M, Bar-Zeev S, van den Broek N. Cause of and factors associated with stillbirth: a 533 
systematic review of classification systems. Acta Obstet Gynecol Scand. 2017;96(5):519-28. 534 
56. Wojcieszek AM, Reinebrant HE, Leisher SH, Allanson E, Coory M, Erwich JJ, et al. 535 
Characteristics of a global classification system for perinatal deaths: a Delphi consensus study. BMC 536 
Pregnancy Childbirth. 2016;16(1). 537 
57. Leisher SH, Teoh Z, Reinebrant H, Allanson E, Blencowe H, Erwich JJ, et al. Classification 538 
systems for causes of stillbirth and neonatal death, 2009–2014: An assessment of alignment with 539 
characteristics for an effective global system. BMC Pregnancy Childbirth. 2016;16(1):269. 540 
58. Allanson ER, Tuncalp O, Gardosi J, Pattinson RC, Francis A, Vogel JP, et al. Optimising the 541 
International Classification of Diseases to identify the maternal condition in the case of perinatal 542 
death. BJOG. 2016;123(12):2037-46. 543 
59. Allanson ER, Tunçalp Ö, Gardosi J, Pattinson RC, Francis A, Vogel JP, et al. The WHO 544 
application of ICD-10 to deaths during the perinatal period (ICD-PM): results from pilot database 545 
testing in South Africa and United Kingdom. BJOG. 2016;123(12):2019-28. 546 
60. Allanson ER, Vogel JP, Tuncalp, Gardosi J, Pattinson RC, Francis A, et al. Application of ICD-547 
PM to preterm-related neonatal deaths in South Africa and United Kingdom. BJOG. 548 
2016;123(12):2029-36. 549 
61. World Health Organization. The 11th Revision of the International Classification of Diseases 550 
(ICD-11)  [cited 2017 17 Aug]. Available from: http://www.who.int/classifications/icd/revision/en/. 551 
 552 
